BMC Cancer

1. HARRISON TA, Zaidi SH, Yin H, Steinfelder RS, et al
   Genomic characterization of colorectal tumors: insights into significantly mutated genes, pathways, and survival outcomes.
   BMC Cancer. 2025;26:109.
   

   >> Share

   
   
2. YU Y, Jiang X, Pei B, Zhou J, et al
   Proteome profiling reveals early diagnostic biomarker candidates for colorectal cancer.
   BMC Cancer. 2026 Jan 28. doi: 10.1186/s12885-026-15547.
   

   >> Share

   
   

   
   BMC Gastroenterol

3. WEI H, Fu X, Cheng Y, Xu L, et al
   Interpretable machine learning model for predicting 5-Year postoperative recurrence risk in patients with stage III colon cancer using preoperative laboratory tests: a two-centre study.
   BMC Gastroenterol. 2026;26:72.
   

   >> Share

   
   
4. TEHRANI FR, Asgari N, Jamalli A, Ghaemi EA, et al
   Exploring the link between Mycobacterium avium subsp. Paratuberculosis and colorectal cancer development.
   BMC Gastroenterol. 2026 Jan 24. doi: 10.1186/s12876-025-04597.
   

   >> Share

   
   
5. MA L, Zheng WW, Zhang Y, Wei W, et al
   Analysis of the incidence and risk factors of colorectal polyps in patients with chronic hepatitis B complicated by non - alcoholic fatty liver disease.
   BMC Gastroenterol. 2026 Jan 3. doi: 10.1186/s12876-025-04488.
   

   >> Share

   
   

   
   Cancer

6. O'CONNELL CP, Berndt SI, Chudy-Onwugaje K, Kunzmann A, et al
   Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
   Cancer. 2026;132:e70201.
   

   >> Share

   
   

   
   Cancer Res

7. YUAN Q, Sun Y, Zhang Y, Chen C, et al
   Intratumoral P. copri Reprograms MARCO+ Tumor-Associated Macrophages by Depleting Glycerophosphocholine to Drive Colorectal Cancer Progression.
   Cancer Res. 2026 Jan 27. doi: 10.1158/0008-5472.CAN-25-3400.
   

   >> Share

   
   

   
   Gastroenterology

8. PLUGGE SF, Ma H, van der Vaart JY, Sprangers J, et al
   Intestinal LKB1 Loss Drives a Premalignant Program Along the Serrated Cancer Pathway.
   Gastroenterology. 2026;170:298-314.
   

   >> Share

   
   

   
   Gut

9. VIJAY-KUMAR M, Yeoh BS, Gewirtz AT
   Hydroxylation matters! Microbial bile acid metabolism and colorectal cancer.
   Gut. 2026 Jan 28:gutjnl-2025-337583. doi: 10.1136/gutjnl-2025-337583.
   

   >> Share

   
   

   
   Int J Colorectal Dis

10. GUTLIC I, Veres K, Horvath-Puho E, Lydrup ML, et al
    Follow-up intensity after colorectal cancer surgery in patients aged 70 years - an analysis within the COLOFOL randomised clinical trial.
    Int J Colorectal Dis. 2026;41:47.
    

    >> Share

    
    
11. LAN K, Zeng H, Xue X, Liao B, et al
    Comparative efficacy of reinforced suturing, transanal drainage tube, and no additional intervention in preventing anastomotic leakage after rectal cancer surgery: a network meta-analysis.
    Int J Colorectal Dis. 2026;41:45.
    

    >> Share

    
    
12. HEW J, Mohtashami A, Mastrocostas K, Skinner T, et al
    Optimising response assessment to neoadjuvant therapy in rectal cancer to reduce the incidence of ypT0N0 resection.
    Int J Colorectal Dis. 2026;41:50.
    

    >> Share

    
    

    
    J Clin Oncol

13. ZWANENBURG ES, El Klaver C, Wisselink DD, Punt CJA, et al
    Erratum: Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial.
    J Clin Oncol. 2026 Jan 29:JCO2600094. doi: 10.1200/JCO-26-00094.
    

    >> Share

    
    

    
    J Natl Cancer Inst

14. COURNEYA KS, Booth CM, Vardy JL, Friedenreich CM, et al
    Effects of a structured exercise program on motivational outcomes in patients with Colon cancer.
    J Natl Cancer Inst. 2026 Jan 29:djag023. doi: 10.1093.
    

    >> Share

    
    
15. PINSKY PF
    Endoscopic screening for colorectal cancer: efficacy versus effectiveness.
    J Natl Cancer Inst. 2026 Jan 20:djaf384. doi: 10.1093.
    

    >> Share

    
    

    
    J Pathol

16. BRAUTIGAM K, Baker AM, Koelzer VH, Kather JN, et al
    Integrating artificial intelligence (AI) into colorectal cancer reporting.
    J Pathol. 2026 Jan 26. doi: 10.1002/path.70029.
    

    >> Share

    
    

    
    PLoS Biol

17. ZHOU Z, Lu Y, Li P, Liu X, et al
    The lipid-metabolic enzyme HSD17B12 drives lysosomal degradation of PD-L1 potentiating anti-tumor immunity in a mouse model.
    PLoS Biol. 2026;24:e3003603.
    

    >> Share

    
    

    
    PLoS One

18. IBRAHEEM W, Alsheikh F, Alzain AA, Bhongade BA, et al
    Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy.
    PLoS One. 2026;21:e0338123.
    

    >> Share

    
    
19. 
    Retraction: Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway.
    PLoS One. 2026;21:e0341384.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share